Leveraging Advanced Models to Complement Preclinical Safety & Combination Risk Assessment

10:00 am - Monday 8th March 2027

  •  Understanding the potential clinical toxicity of ADCs in the discovery space is critical for next-generation ADC design
  • Discussing how preclinical models can help understand potential safety/clinical liabilities and test possible solutions
  • How to effectively assess the risks of pre-clinical safety

Speakers:

Distinguished Scientist, Discovery Chemistry
Merck & Co